187 related articles for article (PubMed ID: 25750761)
1. Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment.
Qiu WQ; Li H; Zhu H; Scott T; Mwamburi M; Rosenberg I; Rosenzweig J
J Diabetes Metab; 2014 Nov; 5(11):. PubMed ID: 25750761
[TBL] [Abstract][Full Text] [Related]
2. Positive association between plasma amylin and cognition in a homebound elderly population.
Qiu WQ; Au R; Zhu H; Wallack M; Liebson E; Li H; Rosenzweig J; Mwamburi M; Stern RA
J Alzheimers Dis; 2014; 42(2):555-63. PubMed ID: 24898659
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
Mäkimattila S; Fineman MS; Yki-Järvinen H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
[TBL] [Abstract][Full Text] [Related]
6. Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.
Knowles NG; Landchild MA; Fujimoto WY; Kahn SE
Diabetes Care; 2002 Feb; 25(2):292-7. PubMed ID: 11815498
[TBL] [Abstract][Full Text] [Related]
7. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
[TBL] [Abstract][Full Text] [Related]
8. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats.
Gedulin BR; Young AA
Diabetes; 1998 Jan; 47(1):93-7. PubMed ID: 9421380
[TBL] [Abstract][Full Text] [Related]
10. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.
Lutz TA; Rand JS
Can Vet J; 1996 Jan; 37(1):27-34. PubMed ID: 8746416
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of feline diabetes mellitus.
Lutz TA; Rand JS
Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
[TBL] [Abstract][Full Text] [Related]
12. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
[TBL] [Abstract][Full Text] [Related]
13. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
Ly H; Despa F
Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
[TBL] [Abstract][Full Text] [Related]
14. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
Ludvik B; Lell B; Hartter E; Schnack C; Prager R
Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
[TBL] [Abstract][Full Text] [Related]
15. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
[TBL] [Abstract][Full Text] [Related]
16. Insulin treatment improves relative hypersecretion of amylin to insulin in rats with non-insulin-dependent diabetes mellitus induced by neonatal streptozocin injection.
Hiramatsu S; Inoue K; Sako Y; Umeda F; Nawata H
Metabolism; 1994 Jun; 43(6):766-70. PubMed ID: 8201968
[TBL] [Abstract][Full Text] [Related]
17. Amylin in the insulin resistance of patients with rheumatoid arthritis.
Ferraz-Amaro I; López-Mejias R; Tejera-Segura B; de Vera-González AM; Ubilla B; Olmos JM; Hernández JL; González-Gay MA
Clin Exp Rheumatol; 2018; 36(3):421-427. PubMed ID: 29352842
[TBL] [Abstract][Full Text] [Related]
18. Amylin at the interface between metabolic and neurodegenerative disorders.
Lutz TA; Meyer U
Front Neurosci; 2015; 9():216. PubMed ID: 26136651
[TBL] [Abstract][Full Text] [Related]
19. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
20. Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling.
Wagoner PK; Chen C; Worley JF; Dukes ID; Oxford GS
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9145-9. PubMed ID: 8415669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
